Signal or noise? > Ultragenyx cashes in Genglycos-derived priority review voucher for $210M - FirstWord Pharma >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #competitivemarketing